Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers. - Wikidata - wikimedia - TriplyDB

Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers.

Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers.

http://www.wikidata.org/entity/Q34206463

about

When and where does inflammation begin in rheumatoid arthritis?Optimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vector Characteristics of memory B cells elicited by a highly efficacious HPV vaccine in subjects with no pre-existing immunity Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice.A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls.Sublingual immunization of trivalent human papillomavirus DNA vaccine in baculovirus nanovector for protection against vaginal challenge.The lung may play a role in the pathogenesis of rheumatoid arthritis.Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype.Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.Sublingual delivery of vaccines for the induction of mucosal immunity Induction of mucosal immunity through systemic immunization: Phantom or reality?Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques.Impaired T Cell-dependent Humoral Immune Response Associated with Juvenile-onset Recurrent Respiratory Papillomatosis Progression Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates.Cross-neutralizing antibodies elicited by the Cervarix® human papillomavirus vaccine display a range of Alpha-9 inter-type specificities.Challenges in mucosal vaccines for the control of infectious diseases.Recent progress in vaccination against human papillomavirus-mediated cervical cancer.

P2860

Q33662199-EBF66D0A-5C80-4A5A-A8BD-2E41EF155DF8 Q34166320-201B5CB0-AE33-4F99-B85F-DE12C11A4005 Q34352416-17B2B562-CB86-4AE3-9502-AD4761AE3FEE Q34492140-74B61214-ED11-4544-9899-68460FC80746 Q34524955-57CDED84-1BA2-42B7-B574-36552B9E45F6 Q34708325-441EF90E-A836-4FBD-A0E7-F6678225D863 Q35196568-FD63CE92-D8BB-4903-9712-A2B30F99C152 Q35747705-E590B2A6-C92D-4FCC-88A2-4780C019597C Q35861286-F80824C0-2273-42AA-9490-002E3DDC6E7D Q36858686-8245A08A-0D67-4626-86CE-237C234C975E Q36978334-3EC2543D-3C9D-4570-9297-EDF3E8DCFD39 Q37034096-5630CF10-4788-435E-923A-E191D4C15986 Q37130744-01B5233B-5948-4DCA-B39C-CB811337E8E8 Q37320147-DC9F4950-EDFF-4CD3-8444-D1D5B55C1664 Q37399606-F5384588-0AF2-41C6-83AF-5A206B2C12F6 Q37617455-D4ACBF1E-FE7D-4BA8-BCE5-4F4E5FE1071C Q37671423-EFB4970F-783D-4515-A99B-51EF2B409745 Q38219010-CB15B38A-A7D3-409F-9A99-EEB48C2E29BA Q38370782-83C8B4CF-9DD3-4ADC-B920-96A195543E5E

P2860

Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers.

http://www.wikidata.org/entity/Q34206463

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Systemic and mucosal immune re ...... in healthy female volunteers.

@ast

Systemic and mucosal immune re ...... in healthy female volunteers.

@en

Systemic and mucosal immune re ...... in healthy female volunteers.

@nl

type

label

Systemic and mucosal immune re ...... in healthy female volunteers.

@ast

Systemic and mucosal immune re ...... in healthy female volunteers.

@en

Systemic and mucosal immune re ...... in healthy female volunteers.

@nl

prefLabel

Systemic and mucosal immune re ...... in healthy female volunteers.

@ast

Systemic and mucosal immune re ...... in healthy female volunteers.

@en

Systemic and mucosal immune re ...... in healthy female volunteers.

@nl

P1433

Q34206463-981E320A-0199-4513-B854-B2CFB96AF130

P1476

Q34206463-AACAB7F0-536B-4658-8CDA-23BF7443B278

P2093

Q34206463-0950E8CE-B648-4E1D-9D44-F020A31DF58B

Q34206463-6ACFC69C-A797-4C85-9DEE-2BBAE8E8849C

Q34206463-92B12B1A-306E-4B07-AA75-3EF04FA92A4C

Q34206463-957D25BD-E7E0-4AB0-A365-F11765EE88DB

Q34206463-CE2A0048-C7F5-408E-803E-ED0B059492E9

Q34206463-D023611F-D9A7-4192-942D-C0D8F0D330CC

P2860

Q34206463-02392591-0D66-499E-8B20-DF51A62E7670

Q34206463-09071BFB-2417-4636-8CBB-544C27F15D71

Q34206463-10A8864C-046B-40CF-AE16-DFE8A0D038F8

Q34206463-13B836D3-2AF2-4DAD-AEB1-9F0D9C1B9DD0

Q34206463-2325FB02-30D0-4CD7-9E17-4BCD3FA46894

Q34206463-2BA93A85-D814-40F5-97AA-C89B60455E99

Q34206463-5840C16B-68A9-4D47-B303-CBEB920A88B7

Q34206463-5910CC2E-173B-460B-BA32-75E64BC02525

Q34206463-625DD261-5AD6-4C6E-8C91-2B642DFCE510

Q34206463-678E560A-A049-4CC1-85C9-2E431A8BA430

P304

Q34206463-923CEBDF-1C6B-4FEE-B5EA-54011F7237E6

P31

Q34206463-CFB719BC-EFDF-492A-AF28-B5A060E5620B

P356

Q34206463-7B77B54E-8122-48AC-8087-22C374E0B1D5

P407

Q34206463-55F79FCB-A35F-438A-8D80-2473A165E2CD

P433

Q34206463-3ED187D5-5389-4A26-8512-A88C6F1559F1

P478

Q34206463-0A0EC5A9-D9BF-4B7B-B29E-1AFE3E804BC4

P577

Q34206463-7220FE2E-C68D-423B-80CC-E34B94BD0FA8

P5875

Q34206463-9769D10A-4F7F-47CB-8085-B3C01E30AB79

P698

Q34206463-BB056335-40EA-48E0-8FFB-EDAD79E6735E

P932

Q34206463-CCFAB017-14F6-496A-A615-DC8EBF6432A6

P356

JOURNAL.PONE.0033736

P1433

P1476

Systemic and mucosal immune re ...... in healthy female volunteers.

@en

P2093

Clarissa Oeser

http://www.w3.org/2001/XMLSchema#string

David J M Lewis

http://www.w3.org/2001/XMLSchema#string

Raphaela Giemza

http://www.w3.org/2001/XMLSchema#string

Sara L Bissett

http://www.w3.org/2001/XMLSchema#string

Simon Beddows

http://www.w3.org/2001/XMLSchema#string

Zhiming Huo

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Correlating immunity with protection for HPV infection.

Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin.

Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally

Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.

Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a

Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera.

Sublingual vaccination with influenza virus protects mice against lethal viral infection.

Prevalence of human papillomavirus antibodies in young female subjects in England

Mucosal immunization application to allergic disease: sublingual immunotherapy.

P304

e33736

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0033736

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221967883

http://www.w3.org/2001/XMLSchema#string

P698

22438987

http://www.w3.org/2001/XMLSchema#string

P932

3306286

http://www.w3.org/2001/XMLSchema#string